"This is very exciting, clearly, because here we have somebody who can have anaphylaxis and deadly reaction from trace amounts, and you're converting this person into somebody who can tolerate a significant amount of the food, " said Dr. Anna Nowak-Wegrzyn, associate professor of pediatrics at Mount Sinai Medical Center in New York.
CNN: 'Exciting' advance reported in peanut allergy therapy